Saudi­Vax and Mil­li­pore­Sig­ma team up to man­u­fac­ture do­mes­tic vac­cine for the Ara­bi­an penin­su­la

As Sau­di Ara­bia works to get its do­mes­ti­cal­ly-pro­duced vac­cines in­to the arms of res­i­dents, it’s en­list­ed the help of Mer­ck KGaA, Darm­stadt, Ger­many to take on man­u­fac­tur­ing du­ties.

Mil­li­pore­Sig­ma, the US and Cana­di­an life sci­ence di­vi­sion of Mer­ck KGaA, Darm­stadt, Ger­many, and Saudi­Vax will first con­cep­tu­al­ize the process and de­ter­mine the equip­ment need­ed be­fore fit­ting out the fa­cil­i­ty and work­ing out process de­vel­op­ment. Saudi­Vax em­ploy­ees will head to France to train at Mer­ck’s end-to-end GMP site in Mar­tillac, and its M Lab Col­lab­o­ra­tion Cen­ter in Mosheim.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.